C2i Genomics Raises $100M in Funding

20 Apr, 2021

C2i Genomics Raises $100M in Funding

– C2i Genomics from New York, NY provides a cloud-based cancer diagnostics service that uses AI pattern recognition and whole-genome analysis to provide rapid and accurate detection of residual disease.
– The company raised $100m in financing.
– The round was led by Casdin Capital with participation from NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others.
– The new investment will be used to accelerate the company’s clinical development and commercialization of its C2-Intelligence Platform.

Genetics Health Care Health Diagnostics North America Therapeutics Wellness
Crunchbase icon

Content report

The following text will be sent to our editors: